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ABSTRACT
Introduction: Patient treatment satisfaction
and adherence may be affected by the initial
understanding of outcomes in the treatment of
actinic keratoses with 5-fluorouracil 5% cream
(5-FU). Pre-treatment educational videos may
optimize this understanding. The objective of
this study was to determine whether
prospective patient viewing of an educational
video delineating treatment effects and
expectations improves patient satisfaction and
treatment completion rates for the treatment of
actinic keratoses with 5-FU.
Methods: Forty-four participants were recruited
to the UC Davis Dermatology outpatient clinic.
Each participant was randomized to the video
(group A) or control group (group B), and
topical 5-FU cream treatment was conducted
for 2 weeks in both groups.
Results: A follow-up questionnaire was
performed to assess patient satisfaction and
adherence to the treatment regimen. The
results of these questions were analyzed using
the Mann-Whitney test. One item on the
questionnaire asked the patient to rate their
overall level of satisfaction on a score of 0–100.
The results of this question were analyzed using
the unpaired t test. The results of the statistical
analysis show no significant difference between
the patient group that viewed the video and the
patient group that did not view the video.
Conclusions: We speculate that this study may
establish a foundation for subsequent studies
that may affect the broader medical community
and promote development of educational
videos.
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INTRODUCTION
Patient understanding and recall of medical
instructions have a significant impact on the
success of medical treatment. Makki and
colleagues demonstrated that written
postoperative instructions resulted in
decreased discomfort, consumption of fewer
analgesics and a more prompt resumption of
regular activities [1]. In addition, studies have
demonstrated that educational videos are
beneficial in the improvement of melanoma
awareness [2], promotion of sunscreen use [3]
and facilitation of chronic disease management
[4]. Educational videos have also shown utility
in informed consent proceedings for surgical
procedures [5–7].
Topical 5-fluorouracil (5-FU) is an effective
treatment for actinic keratoses [8]. Despite its
widespread use, patient satisfaction rates are less
than optimal. In a questionnaire study
comparing multiple topical therapies for
actinic keratoses, 38% of patients were
‘‘extremely or very satisfied’’ with topical 5-FU
therapy, while 61% were ‘‘somewhat,’’
‘‘minimally’’ or ‘‘not satisfied’’ with treatment
[9]. Poorly defined treatment expectations and
long treatment courses may contribute to low
patient satisfaction following treatment with
5-FU. Viewing a pre-treatment educational
video may provide optimized preparation for
effects of treatment, which may improve
patient satisfaction and treatment completion
rates with 5% 5-FU for treatment of actinic
keratoses. The present study aims: (1) to
determine whether a pre-treatment video
delineating treatment effects and expectations
improves patient satisfaction and treatment
completion rates, compared to usual verbal
instruction, regarding administration of
topical 5% 5-fluorouracil cream for the
treatment of actinic keratosis involving the
face, scalp, upper chest, dorsal hands and
forearms.
METHODS
A total of 44 participants were recruited to the
UC Davis Dermatology outpatient clinic. The
institutional review board at this site approved
the research protocol. Each participant
presented for a regularly scheduled office visit
for AKs needing field therapy such as 5-FU.
Each participant signed an informed consent
form and was randomized to the video or
control group though a standardized
randomization process. A participant
randomized to the video group (group A)
viewed a brief video on 5-FU treatment
(physician absent) after a brief introduction
to 5-FU treatment by the MD provider. The
participant in the control group (group B)
received the usual verbal instruction on 5-FU
treatment and had all questions answered by
the MD provider as would be done in a
standard dermatology office visit. For both
interventions, the proper use and potential
adverse effects of the treatment were discussed.
The video also included clinical images of
expected treatment effects during treatment.
The treatment for 5-FU cream began within
3 weeks of enrollment. The participant was
instructed to apply topical 5-FU cream twice
daily for 2 weeks. The follow-up questionnaire
(Table 1) was performed via telephone and
completed within 6 weeks of completing
treatment. The ten-item questionnaire was
designed to assess participant satisfaction and
treatment adherence.
In this pilot study, the number of subjects
(22 per study arm, 44 total) was based on data
from a study by Tierney and colleagues [9] in
which 45 patients were surveyed in a study
evaluating patient satisfaction with various
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treatment options for actinic keratoses. Of the
original 45 subjects enrolled, 39 returned the
mail-in questionnaires with an 86.7%
completion rate. The researchers found that
photodynamic therapy had equivalent or
improved recovery times, cosmetic outcomes,
patient satisfaction and preference as a
treatment for actinic keratoses when compared
Table 1 Post treatment questionnaire for groups A and B
1. What is your overall level of discomfort during
treatment with cream:
a. None
b. Minimal
c. Moderate
d. Severe
2. How long did it take for your skin to return to
‘‘normal’’ after completing the 5-FU treatment:
a. Less than 7 days
b. 7 to 14 days
c. 14 to 21 days
d. More than 21 days
3. How much did the 5-FU treatment disrupt your
everyday life?
a. Significantly
b. Somewhat
c. Slightly
d. Not at all
4. How do you feel about the appearance of your skin
after 5-FU treatment?
a. Much improved
b. Improved
c. Unchanged
d. Worse
5. How do you feel about the overall effectiveness of the
5-FU treatment?
a. Very effective
b. Moderately effective
c. Slightly effective
d. Not effective
6. How satisfied are you with the doctors who treated
your pre-cancers (actinic keratoses)?
a. Very satisfied
b. Somewhat satisfied
Table 1 continued
c. Minimally satisfied
d. Not satisfied
7. How likely are you to recommend this treatment to
others with similar skin conditions?
a. Would strongly recommend
b. Would recommend with some confidence
c. Would recommend with hesitation
d. Would not discuss
e. Would discourage others from using this treatment
8. Did you complete your treatment as instructed by
your dermatologist? Choose one of the following:
a. I applied the cream every single day of treatment
b. There are 1 to 3 days when I missed at least one dose
c. There are 4–7 days when I missed at least one dose
d. There are over 7 days when I missed at least one dose
e. I stopped the treatment early (please state reason
why treatment was stopped below):
9. Please rate your level of understanding of what to
expect during and after treatment with Efudex:
a. Excellent
b. Very Good
c. Ok
d. Poor
10. What is your overall level of satisfaction with the
5-FU treatment? Please provide a score from 0 to 100,
with 0 being the worst and 100 being the best
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to other treatment options. Although ours is a
pilot study, we would like to note that these
results reached statistical significance.
Our study had 90% power to detect a 1-cm
difference in satisfaction on a 10-cm visual
analog scale with a = 0.05 if 20 subjects were
recruited in each group. We then accounted for
10% subject dropout and therefore recruited 22
subjects for each treatment arm for a total of 44
total subjects. The chosen effect size represented
clinically meaningful difference based on both
the prior literature and its comparability to
seven-point categorical satisfaction scales.
The results of a patient satisfaction survey
were analyzed to evaluate the hypotheses
H0 = patient satisfaction of treatment does not
increase with the educational video vs.
H1 = patient satisfaction of treatment does
increase with the educational video. A survey
of 10 questions was administered to 44
participants; 22 had watched the video, and
22 had usual verbal instruction. Thirty
participants completed the survey, though not
all were completed in entirety; 68% of the
patients responded to the survey, 64% of group
A and 73% of group B. This response rate was
slightly less than the allotted 10% drop-out rate
per the research plan. Responses for individual
questions ranged from n = 28 to n = 30.
Questions 1 through 9 were categorical
responses measuring patient satisfaction of
treatment. The results of these questions were
analyzed using the Mann-Whitney test.
Question 10 asked the patient to rate their
overall level of satisfaction on a score of 0 to
100. The results of this question were analyzed
using the unpaired t test. If the sample size had
been larger it would have been beneficial to
compute a chi-square test to determine odds
ratios for categorical responses.
Compliance with Ethics Guidelines
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
Table 2 Statistical analysis
Mann-Whitney B test
Question P value nA nB MedianA MedianB 25% A 25% B 75% A 75% B
Ql 0.432 14 15 2.5 3 1 2 3 3
Q2 0.207 12 16 2 2 2 1 3 2
Q3 0.176 14 16 4 3 2 2 4 4
Q4 0.446 14 16 2 2 1 1 3 2
Q5 0.669 13 16 2 1.5 1 1 2.5 2
Q6 0.209 14 16 1 1 1 1 1 1
Q7 0.907 13 16 2 2 1 1 2 2
Q8 0.330 14 15 1 1 1 1 1 2
Q9 0.965 14 16 2 2 1 1 2.25 2
T test
Q10 0.633 13 16 90 90 72.5 85 94 93.75
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2013. Informed consent was obtained from all
patients for being included in the study.
RESULTS
The results of the statistical analysis show no
significant differences between the patient group
that viewed the video (group A) and the usual
verbal instruction group (group B). P values for
all of the results are greater than 0.05. Table 2
shows, for each question, the p value, sample size
for groups A and B, the median value of response
for groups A and B, and the 25th and 75th
percentiles for groups A and B.
DISCUSSION
Proper pre-treatment instruction is vital in
alleviating anxiety and apprehension about the
use of 5-FU cream for treatment of actinic
keratoses. Furthermore, this may improve
management of diffuse actinic damage and
possibly decrease the incidence of squamous
cell carcinomas developing from actinic
keratoses. In the present study, viewing an
educational video prior to treatment did not
lead to statistically significant differences in
patient satisfaction and treatment completion
rates when compared to usual verbal instruction.
Our results show no significant differences
between the video and usual verbal instruction
group, with regards to the questionnaire
responses (Table 1). For example, when asked:
‘‘How satisfied are you with the doctors who
treated your pre-cancers (actinic keratoses)?’’ in
Q6, 10 of 12 (83%) selected ‘‘very satisfied’’ in
the video group, while 18 of 18 (100%) selected
‘‘very satisfied’’ in the usual verbal instruction
group. This difference was not found to be
statistically significant. Additionally, when
asked: ‘‘Did you complete your treatment as
instructed by your dermatologist?’’ in Q8, 12 of
12 (100%) missed doses 3 days or less during the
treatment period in the video group, whereas 17
of 18 (94%) missed doses 3 days or less in the
usual verbal instruction group. Again, this
difference was also not found to be statistically
significant.
Our findings present a few implications. First
of all, the patient educational video may
provide the same high level of satisfaction as
the usual verbal instruction group, as evidenced
by the median Q10 score of 90 out of 100,
where 100 represented the highest level of
general satisfaction, in both the video and
usual verbal instruction group. Given this, one
can argue that showing patient education
videos as a substitute to usual verbal
instruction in the office will yield identical
treatment outcomes in the context of a
complicated medical regimen as in the case of
5-FU treatment for actinic keratosis. Not only
may this yield identical treatment outcomes
and patient satisfaction, but the option of
employing patient educational media such as
video yields increased clinic efficiency and
opportunities for a multidisciplinary approach
to pre-treatment education, as various members
of the care team including nursing staff and
medical assistants can play a key role in
delivering the media to the patient in the
office setting.
Potential limitations to the study are as
follows: There is a small sample size and
results do not reach statistical significance.
Also, the method of MD instruction was not
standardized. The video group received an
introduction to the concept of 5-FU treatment
by the treating MD, which was not standardized
or scripted across providers, and multiple MDs
were involved in the instruction process for
both groups. This introduction was understood
to be significantly abbreviated compared to the
usual verbal instruction given to the control
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group. This introduction may be perceived as
full MD counseling in members of the video
group and leaves the meaning of an
introduction to 5-FU up to interpretation by
the provider, leading to variation regarding the
depth and detail of this treatment introduction.
Furthermore, given that the questionnaires
were not anonymous as they were performed
via telephone with an MD provider, the
participants may have felt a desire to please
the MD by responding in a generally affirmative
manner regarding their level of satisfaction. A
fully anonymous modality for feedback might
yield more accurate results in a future study.
CONCLUSION
No significant differences in patient satisfaction
were found between the patient group that
watched the video and the patient group that
did not watch the video. A larger sample size
could have produced a more robust analysis. We
speculate that this study may establish a
foundation for subsequent studies that may
affect the broader medical community and
promote development of educational videos
for additional arenas of patient care, including
wound care and medications requiring
self-injection.
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